Evidence map›Paper›PMID 22158781›Full record

ArticleJournal of leukocyte biology2012

Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Qing Li, Xuedong Ding, Jeremy J Thomas, Clifford V Harding, Nicole D Pecora, Assem G Ziady, Samuel Shank, W Henry Boom, Christina L Lancioni, Roxana E Rojas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Qing LiDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Xuedong Ding
Jeremy J Thomas
Clifford V Harding
Nicole D Pecora
Assem G Ziady
Samuel Shank
W Henry Boom
Christina L Lancioni
Roxana E Rojas
Case Western Reserve University · USUniversity School · USHarvard University Press · USOregon Health & Science University · US

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Regulation of macrophages by Mycobacterium tuberculosisR01AI034343 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 1994 to 2017
$6.2M
HETEROGENEITY OF TCELLS IN M TUBERCULOSIS INFECTIONR01AI027243 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY · 1989 to 2016
$5.5M
MYCOBACTERIUM TUBERCULOSIS INFECTION IN THE LUNGR01HL055967 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY · 1995 to 2010
$4.2M
CLASS II MHC TRANSPORT AND FUNCTIONR01AI035726 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 1994 to 2010
$3.0M
M. tuberculosis lipoprotein-TLR2 interactionsR01AI069085 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2007 to 2011
$1.9M
MTB directly regulates human CD4+ T cell activationK08AI083739 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANCIONI, CHRISTINA LOUISE · 2009 to 2013
$637k
NHLBI NIH HHS HL055967NHLBI NIH HHS R01 HL055967NIAID NIH HHS AI027243NIAID NIH HHS AI034343NIAID NIH HHS AI035726NIAID NIH HHS AI069085NIAID NIH HHS HHSN266200400091CNIAID NIH HHS HHSN266200700022C/NO1-AI-70022NIAID NIH HHS K08 AI083739NIAID NIH HHS N01 AI070022NIAID NIH HHS P30 AI036219NIAID NIH HHS R01 AI027243NIAID NIH HHS R01 AI034343NIAID NIH HHS R01 AI035726NIAID NIH HHS R01 AI069085
6 · The paper itself

Abstract

Mtb regulates many aspects of the host immune response, including CD4+ T lymphocyte responses that are essential for protective immunity to Mtb, and Mtb effects on the immune system are paradoxical, having the capacity to inhibit (immune evasion) and to activate (adjuvant effect) immune cells. Mtb regulates CD4+ T cells indirectly (e.g., by manipulation of APC function) and directly, via integrins and TLRs expressed on T cells. We now report that previously uncharacterized Mtb protein Rv2468c/MT2543 can directly regulate human CD4+ T cell activation by delivering costimulatory signals. When combined with TCR stimulation (e.g., anti-CD3), Rv2468c functioned as a direct costimulator for CD4+ T cells, inducing IFN-γ secretion and T cell proliferation. Studies with blocking antibodies and soluble RGD motifs demonstrated that Rv2468c engaged integrin VLA-5 (α5β1) on CD4+ T cells through its FN-like RGD motif. Costimulation by Rv2468c induced phosphorylation of FAKs and Pyk2. These results reveal that by expressing molecules that mimic host protein motifs, Mtb can directly engage receptors on CD4+ T cells and regulate their function. Rv2468c-induced costimulation of CD4+ T cells could have implications for TB immune pathogenesis and Mtb adjuvant effect.

Indexed as

Bacterial ProteinsCD4-Positive T-LymphocytesFocal Adhesion Kinase 1Focal Adhesion Kinase 2HumansImmunologic MemoryIntegrin alpha5Integrin alpha5beta1Interferon-gammaLymphocyte ActivationMycobacterium tuberculosisOligopeptidesPhosphorylationProtein BindingProtein Interaction MappingProtein Processing, Post-Translationalarginyl-glycyl-aspartic acidBacterial ProteinsFocal Adhesion Kinase 1Focal Adhesion Kinase 2Integrin alpha5Integrin alpha5beta1Interferon-gammaOligopeptidesPTK2 protein, humanReceptors, Antigen, T-CellRv2468c protein, Mycobacterium tuberculosisTumor Necrosis Factor-alpha

Identifiers

PMID22158781
PMCPMC3290430
OpenAlexW2099723078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.